Satellos Bioscience Stock Quote MSCL - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.475

Bid

0.47

Ask

0.49

Volume

17,262

0.465 Day's Range 0.50

0.38 52 Week Range 0.80

Market Cap

53.576M

Previous Close

0.48

Open

0.48

Last Trade

1500

0.475

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

53,225

Shares Outstanding

112,792,000

Dividend Yield

PE Ratio

-3.34

Earnings Per Share (EPS)

-0.14

Revenue

Net Profit

-15.89M

Sector

Coml Physical, Biologcl Resh

Industry

Pharmaceutical Preparations

Website

www.satellos.com

Headquarters

Toronto, Ontario, Can

Founded

2007

Satellos Bioscience Inc is listed in the Coml Physical, Biologcl Resh sector of the Toronto Stock Exchange with ticker MSCL. The last closing price for Satellos Bioscience was $0.48. Over the last year, Satellos Bioscience shares have traded in a share price range of $ 0.38 to $ 0.80.

Satellos Bioscience currently has 112,792,000 shares outstanding. The market capitalization of Satellos Bioscience is $54.14 million. Satellos Bioscience has a price to earnings ratio (PE ratio) of -3.34.

Satellos Announces Submission of Regulatory Filing to Commence a Phase 1 Clinical Trial with SAT-3247

– Investigational New Drug (IND) enabling preclinical and toxicology studies successfully completed – Initiation of a Phase 1 clinical trial of SAT-3247 anticipated in Q3 2024 Satellos Bioscience...

Satellos Presents Preliminary Data Showing Muscle Repair and Regeneration from SAT-3247 Treatment in Canine Model of Duchenne Muscular Dystrophy (“DMD”)

–SAT-3247 treatment improved muscle repair and regeneration in canine model of DMD – SAT-3247 treatment also improved muscle force in this canine model of DMD – Satellos remains on track to...

Satellos Announces Presentation at Parent Project Muscular Dystrophy (PPMD) 30th Annual Conference

– Frank Gleeson, Satellos CEO, to participate in a panel discussion titled "Research Row: PPMD Moving the Needle" on June 29, 2024 – Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSX:...

Satellos Announces Formation of Clinical Advisory Board to Support Advancing SAT-3247 in Clinical Trial Development for Duchenne Muscular Dystrophy

Satellos expects to begin first-in-human clinical trials mid-year for SAT-3247, an oral small molecule drug candidate in development as a novel regenerative medicine approach to treating DMD...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.005	-1.04166666667	0.48	0.51	0.465	14605	0.48518966	CS
4	-0.075	-13.6363636364	0.55	0.56	0.465	42495	0.50329298	CS
12	0.07	17.2839506173	0.405	0.64	0.38	53225	0.51395155	CS
26	-0.145	-23.3870967742	0.62	0.8	0.38	62641	0.5433706	CS
52	-0.145	-23.3870967742	0.62	0.8	0.38	62641	0.5433706	CS
156	-0.145	-23.3870967742	0.62	0.8	0.38	62641	0.5433706	CS
260	-0.145	-23.3870967742	0.62	0.8	0.38	62641	0.5433706	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WINTWindtree Therapeutics Inc	$ 8.24 (150.46%)	48.57M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NBSTWNewbury Street Acquisition Corporation	$ 0.1349 (92.71%)	122.1k
YIBOPlanet Image International Ltd	$ 2.915 (53.43%)	260.07k
CREVCarbon Revolution Public Ltd	$ 9.00 (45.87%)	8.06M
NMHINatures Miracle Holding Inc	$ 0.2035 (-48.06%)	7.69M
TANHTantech Holdings Ltd	$ 0.2585 (-47.23%)	6.75M
DXCMDexCom Inc	$ 64.00 (-40.66%)	53.92M
PSIGPS International Group Ltd	$ 1.42 (-31.40%)	716.26k
POAIPredictive Oncology Inc	$ 1.36 (-27.27%)	6.02M
SLNASelina Hospitality PLC	$ 0.0305 (-18.88%)	408.61M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NVDANVIDIA Corporation	$ 113.06 (0.69%)	293.33M
SQQQProShares UltraPro Short QQQ	$ 9.10 (-2.88%)	176.49M
SGMOSangamo Therapeutics Inc	$ 0.8612 (28.15%)	123.71M